RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23416071http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23416071http://www.w3.org/2000/01/rdf-schema#comment"Lifestyle-related diseases are increasing and the challenge to create innovative drugs to treat such diseases is a main focus in medical science research. Fibroblast growth factor 21 (FGF21) is a powerful modulator of glucose and lipid metabolism, and is an innovative candidate drug already in clinical trials for type 2 diabetes mellitus and obesity. Bone fragility and impaired fracture healing induced by such lifestyle-related conditions are also a growing problem. Bone morphogenic proteins (BMPs) are well known osteogenic growth factors, and BMP-2 is used to augment bone formation in difficult clinical situations. There are many documented interactions between the FGF and BMP family proteins, although the interaction between FGF21 and BMP-2 remains unknown. The aim of this study was to reveal the effect of FGF21 toward BMP-2-dependent osteogenic activity, using C2C12 cells as a model system. We found that FGF21 enhanced BMP-2-dependent transcription and osteogenesis in the C2C12 cell line, which was confirmed by alkaline phosphatase activity, matrix mineralization, and gene expression. Mechanistically, FGF21 enhanced BMP-2-induced intracellular signaling through Smad proteins, but not through p44/42MAPK proteins. Furthermore, we identified a negative feedback loop in which BMP-2 decreased endogenous FGF21 mRNA expression. In summary, this study demonstrates interactions between BMP-2 and FGF21 pathways exist in vitro, and that FGF21 enhances the osteogenic activity of BMP-2 by up-regulating the BMP-2-dependent Smad signaling pathway."xsd:string
http://purl.uniprot.org/citations/23416071http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2013.02.019"xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/author"Ishida K."xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/author"Haudenschild D.R."xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/name"Biochem Biophys Res Commun"xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/pages"677-682"xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/title"Interactions between FGF21 and BMP-2 in osteogenesis."xsd:string
http://purl.uniprot.org/citations/23416071http://purl.uniprot.org/core/volume"432"xsd:string
http://purl.uniprot.org/citations/23416071http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23416071
http://purl.uniprot.org/citations/23416071http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23416071
http://purl.uniprot.org/uniprot/#_A0A7U3L6A3-mappedCitation-23416071http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/#_P21274-mappedCitation-23416071http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/#_Q3V1I4-mappedCitation-23416071http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/#_Q9JJN1-mappedCitation-23416071http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/A0A7U3L6A3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/Q9JJN1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/P21274http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/23416071
http://purl.uniprot.org/uniprot/Q3V1I4http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/23416071